Research Article

OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE

Volume: 6 Number: 1 January 12, 2026
TR EN

OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE

Abstract

Ovarian torsion leads to ischemia and subsequent reperfusion (I/R) injury, resulting in oxidative stress, inflammation, and tissue damage that may impair ovarian function. Olivetol, a natural resorcinol derivative with known antioxidant and anti-inflammatory properties, has not been previously evaluated for its protective potential in ovarian I/R injury. In this experimental study, rats were divided into eight groups: Sham, Sham + Olivetol (100 mg/kg), Ischemia, Ischemia + Olivetol (50 mg/kg), Ischemia + Olivetol (100 mg/kg), Ischemia/Reperfusion (I/R), I/R + Olivetol (50 mg/kg), and I/R + Olivetol (100 mg/kg). Ischemia was induced by clamping the ovarian pedicle for 3 hours’ period, followed by reperfusion in relevant groups. Olivetol was administered orally before ischemia or reperfusion induction. Superoxide dismutase (SOD), glutathione (GSH), myeloperoxidase (MPO), and malondialdehyde (MDA) levels were analyzed in ovarian tissues to assess oxidative and inflammatory changes. SOD activity and GSH levels were significantly decreased in ischemia and I/R groups compared to the Sham group, whereas Olivetol administration dose-dependently restored these antioxidant parameters. In contrast, MPO and MDA levels were markedly elevated following ischemia and reperfusion, indicating increased oxidative stress and inflammation; these parameters were significantly reduced by Olivetol treatment, particularly at the 100 mg/kg dose (p<0.001). High-dose Olivetol showed no toxic effects in healthy rats. Olivetol exerted significant protective effects against ovarian ischemia/reperfusion injury by enhancing antioxidant defenses and reducing oxidative and inflammatory damage. These findings suggest that Olivetol may represent a promising therapeutic candidate for preventing reperfusion-induced ovarian injury and preserving ovarian function.

Keywords

Ethical Statement

This project was approved by the Local Ethics Committee for Animal Experiments of the Faculty of Veterinary Medicine at Atatürk University (approval number: 2300251381, Date: 17.08.2023).

References

  1. Bayir, Y., Cadirci, E., Polat, B., Kilic Baygutalp, N., Albayrak, A., Karakus, E., Un, H., Keles, M. S., Kocak Ozgeris, F. B., & Toktay, E. (2016). Aliskiren–a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS. Gynecological Endocrinology, 32(8), 675-683. https://doi.org/10.3109/09513590.2016.1153055
  2. Bircan, B., Tanyeli, A., Eraslan, E., Akdemir, F. N. E., Yazici, Ş., Güzel, D., Polat, E., & Güler, M. C. (2025). Therapeutic potential of cepharanthine in ovarian ischemia-reperfusion injury: insights from a rat ovarian torsion-detorsion model. Journal of Laboratory Animal Science and Practices, 5(2), 110-118. https://doi.org/10.62425/jlasp.1673052
  3. Bodur, A., Alver, A., Kahraman, C., Altay, D. U., & İnce, İ. (2016). Investigation of N-acetylcysteine on contralateral testis tissue injury by experimental testicular torsion: long-term effect. The American Journal of Emergency Medicine, 34(6), 1069-1074. https://doi.org/10.1016/j.ajem.2016.03.021
  4. Bridwell, R. E., Koyfman, A., & Long, B. (2022). High risk and low prevalence diseases: Ovarian torsion. The American Journal of Emergency Medicine, 56, 145-150. https://doi.org/10.1016/j.ajem.2022.03.046
  5. Cascio, M., Bisogno, T., Palazzo, E., Thomas, A., Van der Stelt, M., Brizzi, A., de Novellis, V., Marabese, I., Ross, R., & Van de Doelen, T. (2006). In vitro and in vivo pharmacology of synthetic olivetol‐or resorcinol‐derived cannabinoid receptor ligands. British Journal of Pharmacology, 149(4), 431-440. https://doi.org/10.1038/sj.bjp.0706888
  6. Ciortan, L., Macarie, R. D., Barbu, E., Naie, M. L., Mihaila, A. C., Serbanescu, M., & Butoi, E. (2025). Cross-talk between neutrophils and macrophages post-myocardial infarction: from inflammatory drivers to therapeutic targets. International Journal of Molecular Sciences, 26(21). https://doi.org/10.3390/ijms262110575
  7. Divya, B., & Narayanan, J. (2022). Evaluation of anti-convulsant activity of olivetol on ptz induced seizure model. NeuroQuantology, 20(16), 372-381. https://doi.org/10.14704/Nq.2022.20.17.Nq88051
  8. Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016). Ischemia/reperfusion. Comprehensive Physiology, 7(1), 113-170. https://doi.org/10.1002/j.2040-4603.2017.tb00741.x

Details

Primary Language

English

Subjects

Structural Biology

Journal Section

Research Article

Early Pub Date

January 12, 2026

Publication Date

January 12, 2026

Submission Date

November 4, 2025

Acceptance Date

January 8, 2026

Published in Issue

Year 2026 Volume: 6 Number: 1

APA
Özkan, H. İ., & Kızıltunç, A. (2026). OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE. Journal of Laboratory Animal Science and Practices, 6(1), 31-38. https://doi.org/10.62425/jlasp.1817497
AMA
1.Özkan Hİ, Kızıltunç A. OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE. Journal of Laboratory Animal Science and Practices. 2026;6(1):31-38. doi:10.62425/jlasp.1817497
Chicago
Özkan, Halil İbrahim, and Ahmet Kızıltunç. 2026. “OLIVETOL MITIGATES OVARIAN ISCHEMIA REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE”. Journal of Laboratory Animal Science and Practices 6 (1): 31-38. https://doi.org/10.62425/jlasp.1817497.
EndNote
Özkan Hİ, Kızıltunç A (March 1, 2026) OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE. Journal of Laboratory Animal Science and Practices 6 1 31–38.
IEEE
[1]H. İ. Özkan and A. Kızıltunç, “OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE”, Journal of Laboratory Animal Science and Practices, vol. 6, no. 1, pp. 31–38, Mar. 2026, doi: 10.62425/jlasp.1817497.
ISNAD
Özkan, Halil İbrahim - Kızıltunç, Ahmet. “OLIVETOL MITIGATES OVARIAN ISCHEMIA REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE”. Journal of Laboratory Animal Science and Practices 6/1 (March 1, 2026): 31-38. https://doi.org/10.62425/jlasp.1817497.
JAMA
1.Özkan Hİ, Kızıltunç A. OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE. Journal of Laboratory Animal Science and Practices. 2026;6:31–38.
MLA
Özkan, Halil İbrahim, and Ahmet Kızıltunç. “OLIVETOL MITIGATES OVARIAN ISCHEMIA REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE”. Journal of Laboratory Animal Science and Practices, vol. 6, no. 1, Mar. 2026, pp. 31-38, doi:10.62425/jlasp.1817497.
Vancouver
1.Halil İbrahim Özkan, Ahmet Kızıltunç. OLIVETOL MITIGATES OVARIAN ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE AND INFLAMMATORY DAMAGE VIA ENHANCEMENT OF ANTIOXIDANT DEFENSE. Journal of Laboratory Animal Science and Practices. 2026 Mar. 1;6(1):31-8. doi:10.62425/jlasp.1817497

Content of this journal is licensed under a Creative Commons Attribution NonCommercial 4.0 International License

29929